Chinese regulators have approved a coronavirus vaccine developed by state-owned pharmaceutical giant Sinopharm, officials announced Thursday.

Sinopharm said yesterday its coronavirus vaccine is 79.34% effective, citing interim analysis of Phase 3 clinical trials.

Though few details were provided, the company said the vaccine met the standards of the World Health Organization and China’s own regulator, the National Medical Products Administration.